Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesSyndromeAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyMice, Inbred C57BLTreatment OutcomeRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationTime FactorsImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseMyelodysplastic SyndromesBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationRetrospective StudiesSevere Combined ImmunodeficiencyT-LymphocytesSurvival AnalysisChimeraColony-Forming Units AssayHLA AntigensLung TransplantationCyclosporineHematologic DiseasesBone DensityActuarial AnalysisFollow-Up StudiesLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyPancytopeniaCarmustineCell DifferentiationOrgan TransplantationSurvival RateLeukocyte CountGraft vs Tumor EffectCytarabineFatal OutcomeGraft vs Leukemia EffectCytomegalovirus InfectionsSpleenBone ResorptionMice, Inbred BALB CGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMelphalanFlow CytometryCells, CulturedEtoposideLymphomaMultiple MyelomaPrognosisMice, KnockoutImmunologic Deficiency SyndromesHodgkin DiseaseAntigens, CD34InfectionDisease Models, Animal